我們已在上線! 進一步了解
BBC圖示

Virtus Biotech Clinical Trials ETF

名稱 持股 交易金額 股數
變動
持股
變動
Goldman Sachs
1
Goldman Sachs
New York
US$190萬 – – –
LPL Financial
2
LPL Financial
California
US$94萬 +US$37.3萬 +19,252 +69%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
US$46.3萬 -US$16萬 -8,255 -25%
Virtu KCG Holdings
4
Virtu KCG Holdings
New York
US$21.3萬 -US$98.6萬 -50,868 -82%
Ladenburg Thalmann Financial Services
5
Ladenburg Thalmann Financial Services
Florida
US$8.6萬 – – –
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
US$3.7萬 +US$2.09萬 +1,080 +123%
Morgan Stanley
7
Morgan Stanley
New York
US$2.6萬 -US$7,756 -400 -23%
Creative Planning
8
Creative Planning
Kansas
US$1.6萬 – – –
UBS Group
9
UBS Group
Switzerland
US$9,000 -US$2.72萬 -1,405 -75%
MSI Financial Services
10
MSI Financial Services
Massachusetts
US$7,000 +US$1,551 +80 +27%
MassMutual Private Wealth & Trust
11
MassMutual Private Wealth & Trust
Connecticut
US$4,724 – – –
Tower Research Capital (TRC)
12
Tower Research Capital (TRC)
New York
US$3,000 -US$4,169 -215 -54%
Citadel Advisors
13
Citadel Advisors
Florida
– -US$94.5萬 -32,531 已平倉
American International Group
14
American International Group
New York
– -US$7,000 -250 已平倉
Next Financial Group
15
Next Financial Group
Texas
– -US$5,000 -204 已平倉
AIA
16
Allegis Investment Advisors
Idaho
– -US$2,000 -85 已平倉